These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10805834)

  • 21. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. At what age should a one-time only colonoscopy for screening of colorectal cancer be performed?
    Delcò F; Sonnenberg A
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1319-20. PubMed ID: 10563547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of screening colonoscopy on outcomes in colorectal cancer.
    Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
    Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk.
    Taksler GB; Perzynski AT; Kattan MW
    Med Decis Making; 2017 Apr; 37(3):204-215. PubMed ID: 27879412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in screening for colorectal cancer--United States, 1997 and 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for colorectal cancer in Italy: 2011-2012 survey.
    Zorzi M; Da Re F; Mantellini P; Naldoni C; Sassoli De'Bianchi P; Senore C; Turrin A; Visioli CB; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):93-107. PubMed ID: 26405781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population.
    Niedermaier T; Weigl K; Hoffmeister M; Brenner H
    Epidemiology; 2018 May; 29(3):397-406. PubMed ID: 29287053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first 3 years of national bowel cancer screening at a single UK tertiary centre.
    Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S
    Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy.
    Lin OS; Kozarek RA; Schembre DB; Ayub K; Gluck M; Drennan F; Soon MS; Rabeneck L
    JAMA; 2006 May; 295(20):2357-65. PubMed ID: 16720821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.